* CVRx Inc reported a quarterly adjusted loss of 57 cents per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of -43 cents. The mean expectation of seven analysts for the quarter was for a loss of 47 cents per share. Wall Street expected results to range from -51 cents to -42 cents per share.
* Revenue rose 27.2% to $13.37 million from a year ago; analysts expected $13.21 million.
* CVRx Inc's reported EPS for the quarter was a loss of 57 cents.
* The company reported a quarterly loss of $13.1 million.
* CVRx Inc shares had risen by 16.8% this quarter and lost 67.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by about 1% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for CVRx Inc is 15.00 This summary was machine generated from LSEG data October 30 at 03:02 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.47 -0.57 Missed
Jun. 30 2024 -0.55 -0.65 Missed
Mar. 31 2024 -0.54 -1.04 Missed
Dec. 31 2023 -0.54 -0.44 Beat
Comments